EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Neoadjuvant chemo-immunotherapy is improved with a novel pulsed electric field technology in an immune-cold murine model

Chiara Pastori, Ebtesam H O Nafie, Mukta S Wagh, Stephen J Hunt, Robert E Neal iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0299499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Chiara Pastori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Galvanize Therapeutics, Redwood City, CA, United States of America. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Galvanize Therapeutics, Inc.,.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemo-immunotherapy uses combined systemic therapies for resectable and unresectable tumors. This approach is gaining clinical momentum, but survival increases leave considerable room for improvement. A novel form of Pulsed Electric Field (PEF) ablation combines focal tissue destruction with immune activation in preclinical settings. The PEFs induce lethal cell damage without requiring thermal processes, leaving cellular proteins intact. This affords PEF a favorable safety profile, improved antigenicity, and significant immunostimulatory damage-associated molecular pattern release compared to other focal therapies. Preclinical investigations demonstrate a combinatorial benefit of PEF with immunostimulation. This study evaluates whether this proprietary PEF therapy induces an immunostimulatory effect sufficient to augment systemic neoadjuvant chemotherapy and immunotherapy to reverse metastatic disease in an immune-cold murine tumor model. To determine whether PEF improves a neoadjuvant chemo-immunotherapy standard-of-care, partial PEF ablation was delivered to orthotopically inoculated 4T1 metastatic tumors in addition to combinations of cisplatin chemotherapy and/or αPD-1 immunotherapy, followed by resection. In addition, to determine whether PEF combined with chemo-immunotherapy improves local and metastatic response in unresectable populations, partial PEF ablation was added to chemo-immunotherapy in mice that did not receive resection. Blood cytokines and flow cytometry evaluated immune response. Partial PEF ablation generates an immunostimulatory tumor microenvironment, increases systemic immune cell populations, slows tumor growth, and prolongs survival relative to neoadjuvant systemic therapies-alone. These data suggest the addition of this proprietary PEF locoregional therapy may synergize with systemic standard-of-care paradigms to improve outcomes with potential or demonstrated metastatic disease in both resectable and unresectable patient cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoadjuvant TherapyNeoplasmsMiceHumansAnimalsDisease Models, AnimalImmunotherapyCisplatinTumor Microenvironment

Substanzen

Cisplatin

Autor:innen und Institutionen

  • Galvanize Therapeutics, Redwood City, CA, United States of America.
  • Hospital of the University of Pennsylvania, Philadelphia, PA, United States of America.

ORCID-Profile: Robert E Neal

Förderung

  • Galvanize Therapeutics, Inc.,

Zitieren

APA

Pastori, C., Nafie, E. H. O., Wagh, M. S., Hunt, S. J., & Neal, R. E. (2024). Neoadjuvant chemo-immunotherapy is improved with a novel pulsed electric field technology in an immune-cold murine model. PLOS ONE. https://doi.org/10.1371/journal.pone.0299499

Vancouver

Pastori C, Nafie EHO, Wagh MS, Hunt SJ, Neal RE. Neoadjuvant chemo-immunotherapy is improved with a novel pulsed electric field technology in an immune-cold murine model. PLOS ONE. 2024. doi:10.1371/journal.pone.0299499

BibTeX
@article{Pastori2024,
  author = {Pastori, Chiara and Nafie, Ebtesam H O and Wagh, Mukta S and Hunt, Stephen J and Neal, Robert E},
  title = {Neoadjuvant chemo-immunotherapy is improved with a novel pulsed electric field technology in an immune-cold murine model},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0299499}
}
Kostenlos starten →